The Mexican consensus on the treatment of hepatitis C

Autor: R. Sandoval-Salas, Juan Francisco Sánchez-Ávila, L.E. Cisneros-Garza, R.A. Chirino-Sprung, I. Aiza-Haddad, F. Higuera-de la Tijera, Omar D. Borjas-Almaguer, R. Trejo-Estrada, M.T. Rizo-Robles, R. Torres-Ibarra, Aldo Torre, M.S. González-Huezo, Judith Flores-Calderón, Margarita Dehesa-Violante, J.L. Poo-Ramírez, Norberto C. Chávez-Tapia, Emmanuel I. Gonzalez-Moreno, A. Flores-Gaxiola, Ignacio García-Juárez, J.A. Mata-Marín, E.R. Marín-López, Nahum Méndez-Sánchez, D. Kershenobich-Stalnikowitz, R. Malé-Velázquez, J.A. Velarde-Ruiz Velasco, Linda E. Muñoz-Espinosa, Roberto Monreal-Robles, Francisco Bosques-Padilla, E. Wolpert-Barraza, S. Navarro-Alvarez, G.E. Castro-Narro, R. Moreno-Alcántar, M. Castillo-Barradas, N. Pavia-Ruz, E. López-Méndez, A.M. Pérez-Ríos, A. Ballesteros-Amozurrutia
Rok vydání: 2018
Předmět:
Zdroj: Revista de Gastroenterología de México (English Edition). 83:275-324
ISSN: 2255-534X
Popis: The aim of the Mexican Consensus on the Treatment of Hepatitis C was to develop clinical practice guidelines applicable to Mexico. The expert opinion of specialists in the following areas was taken into account: gastroenterology, IFNectious diseases, and hepatology. A search of the medical literature was carried out on the MEDLINE, EMBASE, and CENTRAL databases through keywords related to hepatitis C treatment. The quality of evidence was subsequently evaluated using the GRADE system and the consensus statements were formulated. The statements were then voted upon, using the modified Delphi system, and reviewed and corrected by a panel of 34 voting participants. Finally, the level of agreement was classified for each statement. The present guidelines provide recommendations with an emphasis on the new direct-acting antivirals, to facilitate their use in clinical practice. Each case must be individualized according to the comorbidities involved and patient management must always be multidisciplinary.
Databáze: OpenAIRE